German company VSY Biotechnology announced Nov. 12 the European commercial launch of its AcrivaUD Trinova Pro C Pupil Adaptive trifocal presbyopia-correcting intraocular lens (PC-IOL). VSY says the lens is the only trifocal IOL with Sinusoidal Vision Technology that combines with pupil adaptive design.
Bottling Presbyopia Correction
Death, taxes … and presbyopia? One of the few certainties in life, presbyopia is an inevitable part of the natural aging process. Although tools to mitigate the effects of presbyopia are accessible (but seemingly always disappearing [ahem, readers]), several companies are working to develop pharmaceutical solutions to address the condition. This article overviews some products in development.
Visus Therapeutics to Host Its First Capital Markets Day Tomorrow
Visus Therapeutics will host its first Capital Markets Day for investors, analysts, and media tomorrow, August 31, 2021, from 10 am to 2 pm ET at Convene, 530 Fifth Avenue at 45th Street in New York City. During the Capital Markets Day, Ben Bergo, co-founder and chief executive officer; Rhett Schiffman, MD, MS, MHSA, co-founder, chief medical officer and head of …
